Hexal Pharmaceuticals

Hexal is a prominent provider of generic pharmaceuticals, offering a wide range of medications across various therapeutic areas. Founded in 1986, the brand quickly established itself as a leader in the German market by focusing on high-quality, affordable alternatives to off-patent drugs.

Today, Hexal is an integral part of Sandoz, which was formerly a division of the Swiss multinational Novartis. In late 2023, Sandoz was successfully spun off as an independent, publicly-traded company. While the brand remains deeply rooted in Germany, its manufacturing and distribution networks are global, reflecting the extensive reach of its parent company, Sandoz Group AG.